Tian An MedicareCOLRF 36 EBITDA Margin % is -1.57% as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 36/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 71.26% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tian An Medicare's EBITDA for the
six
months ended in Dec. 2025 was $-1.7 Mil. Tian An Medicare's Revenue for the
six
months ended in Dec. 2025 was $109.9 Mil. Therefore, Tian An Medicare's EBITDA margin for the quarter that ended in Dec. 2025 was -1.57%.
Tian An Medicare (OTCPK:COLRF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tian An Medicare EBITDA Margin % Related Terms
Tian An Medicare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Tian An Medicare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COLRF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Tian An Medicare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tian An Medicare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tian An Medicare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tian An Medicare (COLRF) has a EBITDA Margin % of -1.57% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tian An Medicare and its competitors. According to the industry distribution chart, Tian An Medicare ranks #476 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 71.3%.
Is Tian An Medicare's EBITDA Margin % too high?
Tian An Medicare's current EBITDA Margin % is -1.57%. Based on the distribution chart, Tian An Medicare ranks #476 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tian An Medicare has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #476 out of 668 companies for EBITDA Margin %. This places Tian An Medicare in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tian An Medicare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current EBITDA Margin % is -1.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current EBITDA Margin % of -1.57%. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current EBITDA Margin % is -1.57%. Tian An Medicare's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current EBITDA Margin % is -1.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tian An Medicare (COLRF) Overvalued in 2026?
Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued.
The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.
Key valuation signals for COLRF:
EBITDA Margin %: -1.57%
GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
36GF Score
Get the complete analysis for COLRF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COLRF has been successfully added to your 
